![](../../files/images/goods/125150-67-6.png)
OJV-VI
CAS No. 125150-67-6
OJV-VI( —— )
Catalog No. M29201 CAS No. 125150-67-6
OJV-VI is a natural product found in ophiopogonis.
Purity : >98% (HPLC)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
Size | Price / USD | Stock | Quantity |
5MG | 396 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameOJV-VI
-
NoteResearch use only, not for human use.
-
Brief DescriptionOJV-VI is a natural product found in ophiopogonis.
-
DescriptionOJV-VI is a natural product found in ophiopogonis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number125150-67-6
-
Formula Weight855.02
-
Molecular FormulaC44H70O16
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5([C@@H](C[C@@H](C6)O)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)C)O)O[C@H]8[C@@H]([C@H]([C@@H](CO8)O)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)C)C)C)OC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
![](/themes/theme/en/images/ct.png)
![](/themes/theme/en/images/new12.jpg)
![](/themes/theme/en/images/ct2.png)
related products
-
Mesosulfuron-methyl
Mesosulfuron-methyl is a systemic herbicide. It is used for post-emergence control of grasses and other weeds in cereals.
-
MDK1088
MDK-1088 (T.cruzi Inhibitor) is a Trypanosoma cruzi inhibitor.
-
Ac2-26 TFA (151988-3...
Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue.